Translational Development

Beyond mechanics, ProLogium and TDAC provide substantive operational and strategic claims relevant to shareholder redemption calculus. ProLogium states it holds over 1,100 global patents, commercialized a battery design featuring a 100% ceramic separator in 2013, debuted a superfluidized all-inorganic solid-state lithium ceramic battery in 2025, earned a 2026 Edison Awards Gold Award, operates with more than 13 years of manufacturing know-how, and claims to be the only entity globally capable of publicly demonstrating a solid-state battery mass-production line. ProLogium reports shipping more than 800,000 cells from its Taoyuan, Taiwan facility (opened in 2024) and details its European footprint: a Paris-Saclay, France R&D hub launched in May 2024, and a Dunkirk, France GWh-class plant that finished permitting by the end of 2024, with construction slated for 2026, ramp-up projected between Q4 2028 and Q1 2029, and official mass production and deliveries targeted for Q2 2029. These commitments are counterbalanced by risk disclosures noting that failure to secure shareholder approvals, meet the $250 million cash threshold, manage trade disputes or tariffs, validate market acceptance, or mitigate intellectual property and supply-chain risks could delay or terminate the transaction. The exhibit signals active investor outreach ahead of the proxy statement/prospectus and provides concrete capacity and certification metrics for evaluating the viability of holding shares versus taking the $10.73 trust price before the August 24, 2026 deadline.

The extension approval and low redemption rate push the SPAC's deadline beyond the August 24, 2026 cutoff and preserve $156.8mm in trust capital, materially altering the financing footprint and timeline for the ProLogium transaction. CEO Michael Hoffman attributes the shareholder retention to 'excitement' around the deal, claiming ProLogium is a 'global leader in next-generation lithium ceramic battery technology' with a 'gigascale plant in Taiwan and a gigawatt plant in France under construction,' and points to an 'announced total potential subsidy package of up to 1.375 billion from the French Government.' He identifies target markets including electric vehicles, aerospace, robotics, defense, AI data centers, maritime, and energy storage systems that require 'high energy density, fast charging capabilities, enhanced safety, and manufacturability.' The filing's standard disclaimers simultaneously warn that actual results may differ due to risks surrounding the '$250 million Minimum Cash condition,' the ability to commercialize solid-state battery technology, forecast supply and demand, source raw materials, retain key personnel, and navigate U.S. and foreign tariffs.

Extending the deadline removes imminent liquidation pressure and pushes the redemption window beyond the original August 2026 horizon. The 85% retention rate leaves a $156.8mm trust balance, which management highlights as critical for meeting the newly cited $250 million minimum cash threshold. According to Chairman and CEO Michael Hoffman, shareholder enthusiasm stems from the May 27, 2026 merger announcement with ProLogium, which he claims is a 'global leader in next generation lithium ceramic battery technology.' Hoffman specifically asserts the company operates a gigascale plant in Taiwan and has a gigawatt plant in France under construction, backed by a French Government subsidy package potentially reaching up to 1.375 billion to serve electric vehicles, aerospace, robotics, defense, AI data centers, and maritime applications. The explicit anticipation of a forthcoming Form F-4 registration statement signals progression from preliminary discussions toward a definitive proxy/prospectus, where exact conversion ratios, PIPE equity pricing, and sponsor promissory note terms will be formally documented.

The confirmed redemption volume establishes the post-vote trust balance of approximately $156.8mm, directly defining the liquidity pool available for the pending ProLogium transaction ahead of the August 24, 2026 deadline. The explicit mention of the '$250 million Minimum Cash condition' highlights a specific closing hurdle that management must navigate with the remaining trust capital. The 95% extension approval removes immediate liquidation pressure, while the disclosed technological roadmap and facility timelines provide forward-looking context for valuation discussions.

Although promotional and procedurally routine, the posting supplies unaudited operational and technological claims that investors should evaluate against execution risk ahead of the August 24, 2026 redemption deadline. According to the ProLogium-published communication, the company states it has delivered over 2.4 million battery cells worldwide and accumulated more than a decade of mass-production experience. ProLogium claims it holds over 1,100 global patents (granted and pending), launched a next-generation battery architecture featuring a 100% ceramic separator in 2013, introduced a superfluidized all-inorganic solid-state lithium ceramic battery in 2025, and received the Edison Awards Gold Award for that technology in 2026. The filing notes ProLogium possesses more than 13 years of manufacturing know-how, operates a Giga-scale demonstration facility in Taiwan, inaugurated a GWh-class gigafactory in Taoyuan in 2024, and shipped more than 800,000 cells from that location. For international scaling, ProLogium states it established an overseas R&D center in Paris-Saclay in May 2024, expects construction on a Dunkirk, France facility to begin in 2026, anticipates ramp-up beginning between Q4 2028 and Q1 2029, and plans formal mass production and deliveries in Q2 2029. The document explicitly warns that these projections involve material risks—including trade disputes, raw material sourcing, technology commercialization, market acceptance, and key personnel retention—and cautions that actual results may differ materially from corporate statements. Shareholders deciding whether to hold or redeem should treat these capacity and timeline assertions as forward-looking representations subject to regulatory, engineering, and capital execution uncertainties rather than confirmed delivery schedules.

This 8-K recalibrates the investor liquidity and extension clock by locking in a maximum twelve-month delay past the original June 24, 2026 expiration, with the absolute termination floor set at June 24, 2027 unless a Business Combination occurs earlier. The mechanical formula (lesser of $200,000 or $0.03 per share) establishes predictable monthly trust account contributions relative to the remaining 14,651,303 public shares, directly impacting net trust value calculations alongside the reported ~$27,817,433.95 outflow from the 2,598,697 redeemed shares. Compliance with the two-day deposit and five-day notice timelines becomes the primary near-term catalyst. Because the registrant disclosed zero details on deal pipeline, sponsor conduct beyond standard fiduciary procedures, or commercial operations, the filing’s analytical weight rests entirely on deadline management, trust accounting dynamics, and the precise capital reduction from the recorded redemptions.

For TDAC investors, this Rule 425 submission advances the target’s commercial validation narrative without altering the structural mechanics that govern redemptions, trust payouts, or deal extensions. The disclosure of OPmobility’s dedicated module-design and manufacturing role, combined with ProLogium’s cited cell-output volume, patent portfolio depth, and overseas facility sequencing, provides shareholders with tangible operational checkpoints to assess ahead of the proxy/prospectus filing stage. Investors can use these disclosed performance parameters and partnership roadmap items to judge whether the target’s technology maturation supports satisfying the referenced $250 million minimum cash threshold before the August 24, 2026 expiration. Because the contract remains unchanged, the filing’s investment utility centers on calibrating redemption economics and valuation risk against confirmed commercial milestones rather than reacting to revised financial terms or sponsor conduct.

Prologium management promotes Gen 4 superfluidized all-inorganic solid-state lithium ceramic batteries claiming 360–400 Wh/kg gravimetric density and a roadmap to 430–470 Wh/kg utilizing a lithium-metal anode. The company states the cells yield 57 mS/cm ionic conductivity at 25°C, charge 5% to 80% in 5–8 minutes at 400V, retain ≥90% capacity at –20°C, and survive Accelerating Rate Calorimeter testing from ambient to 300–500°C without thermal runaway. Management attributes operational safety to a fully inorganic electrolyte and a ceramic separator certified to withstand 500°C. Manufacturing disclosures indicate the Taoyuan, Taiwan plant shipped over 800,000 cells, held 0.5 GWh capacity in 2025 with a 3.0 GWh maximum design ceiling, and divested a 40 MWh pilot line. The Dunkirk, France facility, with construction scheduled to start in 2026, projects 4.0 GWh by 2030 and a 44.0 GWh maximum design limit, targeting commercial operations by year-end 2029 and Q2 2029 mass production. North American strategy involves multi-state site selection with inlay sourcing from Asia/EU and partner assembly domestically. Capital expenditure estimates are pegged at $10/GWh in Taiwan, $30/GWh in the EU, and $55/GWh in the U.S. The presentation cites over 1,100 global patents, anticipates 1,250 by end-of-2026, and assigns 17% of active patents to top-tier rankings per a 2023 third-party platform. Product roadmaps target automotive, aerospace, data center ESS, and robotics, while invoking BloombergNEF and Recurrent Growth data to characterize BEV headwinds and pivot toward high-safety, fast-discharge emerging markets. All capacity projections, 4–20% pack COGS reduction claims, technical specifications, and market sizing assumptions are designated as management estimates or unverified independent data, subject to financing, permitting, and execution risks with no independent auditor review of the financial projections.

The '$250 million Minimum Cash condition' sets a hard liquidity floor for closing; management warns that high redemption volume depleting trust funds below this threshold could force deal termination unless sponsors deploy alternative capital or roll equity. On operational metrics, management projects Taoyuan gigafactory hitting 0.5 GWh in 2025, scaling to 4.0 GWh by 2030E with a 44.0 GWh max design capacity, while Dunkirk and Taoke sites target 1.05 GWh and >1.0 GWh respectively by 2030E. Prologium claims its Gen 4 lithium ceramic cells deliver 360~400Wh/kg specific energy and 860~940Wh/L pack density, accept ~5~8.5 minutes (5~80%) fast charging, and record 57 mS/cm ionic conductivity per SGS testing. The company also reports shipping 800,000+ cells from its G2 production line between 2024/Q3 and 2025/Q4. However, management explicitly attributes all capacity, cost, and performance projections to internal estimates and third-party literature, disclaims auditor verification, and cautions that results may diverge materially based on available financing, permitting, tariff impacts, and raw material sourcing.

This filing outlines the specific mechanics for extending the SPAC's deadline. The per-share extension payment amount ($0.03) is below the usual $10.00 trust value per share, indicating the trust is not at $10.00/share. The multiple one-month extensions and the small per-share payment highlight that the sponsor is seeking to buy time to complete a deal, and investors need to decide whether to approve these extensions and forgo redemption now, or redeem shares.

For redemption mechanics: TDAC shareholders have the right to redeem their shares in connection with the business combination, but the deal can only close if at least $250 million in cash remains after redemptions. That creates a redemption threshold — if too many shareholders redeem, the deal fails. The sponsor has contractually agreed not to redeem. For trust value: The trust held at least $172.5 million as of the agreement date (per $10.00 per share, though the prompt indicates $10.73 per share due to interest). For extensions: The SPAC's deadline was August 24, 2026; the agreement requires a shareholder vote to extend past June 24, 2026, and the sponsor will fund extension expenses. For deal progress: This is the initial announcement; key conditions include shareholder approvals from both companies, SEC effectiveness of the registration statement, Nasdaq listing, and no stop order. For sponsor conduct: Sponsor waives anti-dilution, locks up for 12 months post-close, and agrees to support the deal and fund extension costs.

This is the definitive business combination agreement consummating the SPAC merger. Redemption mechanics: public shareholders get one ProLogium share per TDAC share, can redeem at trust (~$10.73/share). Trust value is stated as 'at least $172.5 million' and per-share trust value is not the standard $10.00 — the reference price used in the consolidation factor math is $10.00 per share. Closing requires net tangible assets of at least $5,000,001. The $250M Minimum Cash condition means significant redemptions could kill the deal. The extension deadline for TDAC is June 24, 2026, and failure to obtain it gives ProLogium a termination right. Shareholders should track the proxy filing, redemption period, and PIPE subscription progress closely.

Without approval, TDAC would liquidate by June 24, 2026, making the trust proceeds (~$10.63 per share based on $183.3M trust value) returnable to public shareholders and warrants worthless. The extension is essential to complete the proposed ProLogium merger, which is the only announced deal. The filing provides concrete redemption mechanics, sponsor incentives, and conditions for the merger. It also discloses that the sponsor and initial shareholders hold ~21.26% of voting power and have agreed to vote for the extension and not redeem their shares.

The clock is running out: the SPAC must complete a deal by June 24, 2026 or liquidate. The trust has grown to ~10.62 per share, slightly above the 10.10 initial placement. Cash burn and reliance on sponsor loans are intensifying, and disclosure controls are ineffective. No extension or transaction has been disclosed, making this a high-risk, time-critical situation.

A registrant reversing its own controls conclusion only after an SEC comment letter is a credibility signal, and it now says disclosure controls were not effective for all of fiscal 2025 - the period covering its trust accounting and redemption disclosure. Note the tension the amendment leaves in place: the same Item 9A still states management determined internal control over financial reporting WAS effective at December 31, 2025 under COSO 2013, and no material weakness is identified. Cover data: 17,250,000 Class A and 4,657,500 Class B shares outstanding at March 30, 2026.

TDAC is under active SEC staff review: this amendment exists only because of an April 30, 2026 comment letter, and the re-issued certifications indicate the staff pushed back on the original Item 9A language. Nothing financial was restated, controls are still reported effective, and no trust or deadline figure changed, so this is a disclosure-quality event rather than an economic one. Still, SEC review of a blank-check issuer's annual report is a timing risk for any registration statement the company needs cleared for a deal.

This preliminary proxy establishes the definitive operational timeline and voting mechanics governing whether the SPAC survives past June 24, 2026. The Board asserts it believes the current completion window lacks sufficient time to finalize a previously announced business combination, though it explicitly warns there is no guarantee of success through the Extended Date of June 24, 2027. From a redemption calendar perspective, the document mandates that Unit holders must separate their securities into underlying Public Shares and Public Warrants before requesting redemption by the June 15, 2026 cutoff. The filing attributes direct financial conflicts to initial shareholders, confirming the Sponsor and officers collectively hold 4,657,500 Founder Shares representing approximately 21.26% of outstanding Ordinary Shares and purchased 7,075,000 Private Placement Warrants at $1.00 each for $7,075,000 in gross proceeds, all of which the Board affirms will be forfeited upon liquidation. Beneficial ownership tables disclosed in the filing show Magnetar Financial LLC holds 1,300,000 shares, Wolverine Asset Management, LLC holds 1,557,134 shares, and AQR Capital Management, LLC holds 1,099,989 shares out of 21,907,500 total issued shares. Because Cayman Islands law requires a special resolution of at least two-thirds (2/3) of voted shares for approval, the voting power of those institutional blocks becomes operationally decisive. Furthermore, the Risk Factors section warns of regulatory friction under the January 24, 2024 SEC SPAC Rules, potential classification as an investment company under the Investment Company Act of 1940, foreign target clearance delays, and unresolved Passive Foreign Investment Company tax consequences for U.S. Holders exercising redemption rights.

Trust is growing from interest, but cash is nearly gone and sponsor loans are small. No merger agreement, no new target identified, and the clock is ticking toward June 2026 liquidation deadline. Despite healthy trust, the risk of failure to close a deal is rising.

The trust per share has risen to $10.43, providing a small premium over the $10.00 IPO price for redeeming shareholders. The SPAC's cash burn is depleting its working capital, with only $47,150 in cash and a negative working capital position. The sponsor's new $2 million credit line provides some liquidity but signals that the SPAC needs additional funding to continue operations. With a deadline of June 24, 2026, and no deal announced, the pressure is on to consummate a transaction. The going concern warning is a red flag for investors.

The filing contains no assertions regarding customers, revenue, market size, corporate strategy, technology, partnerships, litigation, or personnel changes. Because the document attributes nothing beyond the filers' identities and the SEC form designation, any implication that these entities are preparing for mass redemptions, supporting the announced merger, or pressuring leadership rests solely on subsequent public statements or proxy filings made by the listed holders. As a routine 13G/A, it indicates that at least one reporting person corrected prior data or shifted portfolio weightings, but absent explicit figures or intent disclosures, it provides no standalone guidance on capital allocation, trust preservation, or deal execution timelines.

This sponsorship advance injects operational liquidity without encroaching on the public trust reserve or altering the existing per-share trust balance. Because the maturity trigger is contractually tethered to the pre-existing Amended and Restated Memorandum of Association timeline rather than an extended grace period, the redemption deadline remains intact and no trust liquidation clock is reset. The absolute trust account waiver ensures public shareholders face no secondary claim on their redemption proceeds from this leverage. For deal trackers, the filing signals active sponsor funding and working capital maintenance through August 2025, but introduces no amendment to the business combination window, no change to warrant exercise terms, and no new partnership or target announcements beyond routine financial structuring.

The cash burn and working capital deficit highlight the need for a deal or additional sponsor support before the June 24, 2026 deadline. The new $2 million promissory note from the sponsor signals ongoing sponsor commitment but also indicates the SPAC is relying on sponsor funding to stay afloat. The trust continues to accrue interest, providing a modest per-share buffer for redemptions.

Investors monitoring redemption deadlines should note that the trust per share is $10.21, slightly above the IPO trust value of $10.10, and the deadline is June 24, 2026. The going concern disclosure indicates that the company may run out of cash before completing a deal, which could pressure the sponsor to provide additional funding or accelerate a transaction. The absence of any extension or deal announcement suggests the company is still in early stages of target identification.

As a just-post-IPO document, this filing establishes baseline trust value (~$10.11/share), shows initial cash burn rate, and confirms no target has been identified. It is the primary reference for the ~$10.10 redemption floor. The absence of any extension-related disclosures, working capital loans, or imminent transaction pressures means the redemption deadline calendar is driven solely by the IPO closing date: 18 months from December 24, 2024 = June 24, 2026. Sponsor conduct appears standard – no conflicts of interest beyond typical SPAC disclosures.

What changed: A Rule 425 filing submitted by ProLogium Holding Inc., attaching a July 27, 2026 press release announcing a $50 million committed primary capital investment and referencing the concurrent filing of a Form F-4 registration statement containing a proxy statement/prospectus for the proposed business combination with TDAC. Deal progress advances as the filing marks the deemed filing of a Form F-4 with the SEC under Rules 425 and 14a-12, placing the proxy materials into the regulatory pipeline ahead of a TDAC shareholder meeting. The filing does not alter TDAC’s existing redemption mechanics, trust value ($10.73 per share), or August 24, 2026 deadline; rather, it secures $50 million in committed primary capital from existing ProLogium investors at the previously disclosed pre-money valuation of approximately $3.8 billion to satisfy target financing requirements. Standard risk disclosures in the filing reiterate that consummation remains conditional and explicitly list the level of redemptions by TDAC’s public shareholders as a variable that could impact the transaction’s completion. Why it matters: Strategic and operational claims, attributed to the press release and ProLogium’s corporate profile, state that proceeds will fund scale-up of next-generation lithium ceramic battery production, advance Phase 1 construction of a Dunkirk, France gigafactory (groundbreaking occurred February 2026; designed capacity 4.0 GWh reaching gradually by 2030; total site maximum 44.0 GWh), and expand into data centers, aerospace, and robotics. According to the release, ProLogium management notes the Dunkirk project is supported by a subsidy package of up to €1.375 billion from the Government of the French Republic. Historical output metrics attributed to ProLogium include commercialization starting in 2013, aggregate delivery of more than 2.4 million battery products to collaboration partners and customers, approximately 10,000 automotive application samples, and holding over 1,100 global patents. The Taoke facility in Taoyuan, Taiwan, is described as the first commercial gigafactory to publicly display its production line, with an overseas R&D center established in Paris-Saclay in 2024. Personnel identified in the filing include Vincent Yang as Founder and CEO of ProLogium, Michael B. Hoffman as Chairman and CEO of TDAC, Avanindra C. Das as TDAC Chief Financial Officer, and TDAC board members E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum, and Christopher Jarratt. Financial and legal advisors named include Cohen & Company Capital Markets, Credit Agricole Securities (USA) Inc., Sullivan & Cromwell LLP, LCS & Partners, BTIG, LLC, and Venable.

What changed: 8-K announcing a $50 million PIPE subscription agreement with Naetas Holding Limited for the TDAC/ProLogium business combination. TDAC entered into a Subscription Agreement with Naetas Holding Limited for a $50 million PIPE (5M shares at $10.00 each with 5M warrants) to be funded into escrow pending business combination closing. The subscriber also agreed to non-redemption and non-voting commitments on any offset shares it holds, and the parties agreed to discuss potential business collaboration. Why it matters: The $50M PIPE commitment strengthens the balance sheet for the business combination with ProLogium, providing additional cash to the combined entity. The deadline is August 24, 2026, so this filing indicates progress towards closing in the near term. The trust value per share is $10.73, and the PIPE at $10.00 with warrants provides a slight premium for public shareholders.

What changed: A Form 8-K Current Report filed pursuant to Rule 425 disclosing a Subscription Agreement dated July 27, 2026, executed among Translational Development Acquisition Corp. (“TDAC”), Prologium Holding Inc. (“ProLogium”), and institutional accredited investor Naetas Holding Limited (“Subscriber”). ProLogium and TDAC state they entered into a PIPE subscription for 5,000,000 Class A ordinary shares at $10.00 per share, totaling $50,000,000. The parties agree to issue 5,000,000 accompanying warrants exercisable at $11.50 per share. TDAC’s Chief Executive Officer, Michael B. Hoffman, executed the disclosure. The agreement specifies that Subscribed Shares will cancel into ProLogium Class A ordinary shares at the First Merger Effective Time, one business day after the Subscription Closing. The Subscriber irrevocably waives any claim to the Trust Account. To manage net exposure, the Subscriber can designate currently owned or future open-market purchases of TDAC shares (acquired below the redemption amount) as “Offset Shares”; the agreement mandates that Offset Shares cannot be redeemed for cash and must be submitted via proxy as abstentions on the merger vote. If the Business Combination fails, the Issuer promises to return the Purchase Price and cancel the Subscribed Securities. ProLogium represented it will use commercially reasonable efforts to file a resale registration statement within 45 calendar days post-closing, aiming for effectiveness by day 90 (or day 120 if SEC review occurs). Why it matters: The filing confirms protracted deal funding mechanics that align institutional investor hedging with SPAC trust preservation, ensuring the $50,000,000 gross proceeds remain available to satisfy minimum cash conditions regardless of individual shareholder redemptions. Post-transaction, the PIPE warrants carry a $18.00 per share redemption threshold and a $0.01 per warrant call price, explicitly excluding downward resets or price protection. ProLogium’s management represented a detailed existing equity stack: 21,822,700 Company Common Shares and 67,605,030 Company Preferred Shares issued and outstanding across Series A (19,796,528 shares), Series B (12,807,162 shares), Series C (8,256,445 shares), Series D (2,153,527 shares), Series E (11,601,389 shares), and Series E+ (12,989,979 shares). Additional outstanding instruments cited by the Company include Founder Warrants for 2,286,450 shares at $3.500188, Mercedes-Benz Warrants for 295,244 shares at $25.40275831, and Company Options for 13,500 shares at $0.33. Board approvals noted include 1,450,000 ESOP units at $7.00 and 210,000 units at NT$10.00. Placement agents BTIG, LLC, Cohen & Company Markets, and Credit Agricole Securities (USA) Inc. acknowledged they bear no fiduciary duty and are solely compensated by the Issuer and Company. While parties agreed in good faith to discuss product enhancements and proof-of-concept efforts, the Subscriber maintains they hold no reliance on non-contractual projections. Arbitration under Singapore International Arbitration Centre rules governs disputes. Investors tracking the SPAC’s trust balance face a confirmed $50,000,000 cash infuse contingent on closing, alongside structural protections limiting warrant dilution and mandating specific proxy treatment for offset positions.

What changed: Schedule 13G/A beneficial ownership report amendment filed under the Securities Exchange Act. According to the filing, Wolverine Asset Management, LLC; Wolverine Holdings, LLC; Christopher L. Gust; and Robert R. Bellick are reporting beneficial ownership interests. The provided excerpt contains no share counts, percentage thresholds, transaction dates, or statements of investment purpose. It discloses no modifications to redemption windows, trust account valuations, extension proposals, merger agreement milestones, or sponsor conduct. Why it matters: For a SPAC at the DEAL_ANNOUNCED stage, amended 13G filings are the standard regulatory mechanism for tracking institutional and insider blockholder shifts that can reshape voting coalitions ahead of shareholder approval events. Even without visible numerical data, the naming of these specific holding companies and individuals signals a required update to the SEC that affects public float transparency and shareholder base composition. Investors should retrieve the complete attached exhibit to determine whether any party crossed the five-percent threshold, altered investment intent from passive to active under Rule 13d-1(b), or coordinated with the sponsor or target management—details that directly dictate quorum feasibility, proxy contest exposure, conversion rights, and liquidation pathways.

What changed: Form 8-K Current Report accompanied by Press Release (Exhibit 99.1) announcing that ProLogium Holding Inc. filed an initial Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission. Deal progress advanced as the target entity submitted its Form F-4 registration statement. The filing reports no amendments to the redemption calendar, trust account mechanics, or extension status. Instead, the press release’s forward-looking statement section reiterates active closing prerequisites, attributing ongoing structural risks to a stated "$250 million Minimum Cash condition," the expected fluctuation in the "amount of redemption requests made by TDAC’s public shareholders," and the possibility of "failure to obtain TDAC deadline extension." No adjustments to sponsor conduct or trust valuation are disclosed. Why it matters: The F-4 submission transitions the May 27, 2026-announced de-SPAC business combination into the SEC comment period. As articulated by TDAC Chairman and CEO Michael B. Hoffman, the filing is designed to deliver "significant color into the company and the transaction" through expanded historical and supporting data. Within the same press release, TDAC and ProLogium frame their operational outlook around ProLogium’s "capability of... solid-state battery technology" and "plans to expand globally," while explicitly warning that transaction success depends on satisfying the $250 million minimum cash requirement, navigating shareholder redemptions, and maintaining listing standards before the terminal window closes.

What changed: A Form 425 filing submitted by Prologium Holding Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Exchange Act of 1934, reproducing a June 26, 2026 corporate announcement originally published on LinkedIn, X, and Facebook regarding an upcoming Bloomberg Television interview, combined with standard business-combination disclaimers and participant solicitation notices for the proposed merger with Translational Development Acquisition Corp. The filing confirms no modifications to TDAC’s redemption framework or financing structure; the trust value remains at $10.73 per share and the termination deadline remains August 24, 2026. Regarding deal mechanics, the disclosure explicitly cites a '$250 million Minimum Cash condition' as a prerequisite to closing and warns that 'the amount of redemption requests made by TDAC’s public shareholders' could prevent consummation. It identifies TDAC’s leadership as CEO and chairman Michael B. Hoffman, CFO Avanindra C. Das, and directors E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum, and Christopher Jarratt. No sponsor conduct adjustments, extension proposals, or vote timing changes are recorded. Why it matters: Beyond mechanics, ProLogium and TDAC provide substantive operational and strategic claims relevant to shareholder redemption calculus. ProLogium states it holds over 1,100 global patents, commercialized a battery design featuring a 100% ceramic separator in 2013, debuted a superfluidized all-inorganic solid-state lithium ceramic battery in 2025, earned a 2026 Edison Awards Gold Award, operates with more than 13 years of manufacturing know-how, and claims to be the only entity globally capable of publicly demonstrating a solid-state battery mass-production line. ProLogium reports shipping more than 800,000 cells from its Taoyuan, Taiwan facility (opened in 2024) and details its European footprint: a Paris-Saclay, France R&D hub launched in May 2024, and a Dunkirk, France GWh-class plant that finished permitting by the end of 2024, with construction slated for 2026, ramp-up projected between Q4 2028 and Q1 2029, and official mass production and deliveries targeted for Q2 2029. These commitments are counterbalanced by risk disclosures noting that failure to secure shareholder approvals, meet the $250 million cash threshold, manage trade disputes or tariffs, validate market acceptance, or mitigate intellectual property and supply-chain risks could delay or terminate the transaction. The exhibit signals active investor outreach ahead of the proxy statement/prospectus and provides concrete capacity and certification metrics for evaluating the viability of holding shares versus taking the $10.73 trust price before the August 24, 2026 deadline.

What changed: Form 8-K Current Report containing Exhibit 99.1, a press release titled 'TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote,' announcing the final tabulation of a June 17, 2026 shareholder vote on an extension and redemptions. Mechanics: The press release reports that public shareholders elected to redeem 2,598,697 shares of Class A common stock, leaving holders of 14,651,303 shares to continue holding them. Following these redemptions, approximately $156.8mm remains in the trust account. The extension received 95% of shares voted in favor. The filing also flags a '$250 million Minimum Cash condition' as a prerequisite to closing the business combination. Substance: Attributed to Michael Hoffman, Chairman and CEO of TDAC, the press release describes the proposed target, ProLogium Holding Inc., as a 'global leader in next-generation lithium ceramic battery technology.' Hoffman states the company operates a gigascale plant in Taiwan and has a gigawatt plant in France under construction, backed by an 'announced total potential subsidy package of up to 1.375 billion from the French Government.' He further identifies target markets for the batteries as electric vehicles, aerospace, robotics, defense, AI data centers, and maritime operations. Why it matters: The confirmed redemption volume establishes the post-vote trust balance of approximately $156.8mm, directly defining the liquidity pool available for the pending ProLogium transaction ahead of the August 24, 2026 deadline. The explicit mention of the '$250 million Minimum Cash condition' highlights a specific closing hurdle that management must navigate with the remaining trust capital. The 95% extension approval removes immediate liquidation pressure, while the disclosed technological roadmap and facility timelines provide forward-looking context for valuation discussions.

What changed: A Form 425 submission filed by ProLogium Holding Inc. on June 23, 2026, transmitting a social media and website communications post originally published by ProLogium recounting founder and CEO Vincent Yang’s panel discussion at Battery Show Europe 2026, followed by corporate background descriptions, forward-looking statement disclaimers, proxy solicitation participant disclosures, and standard securities law notices. The filing reports no adjustments to TDAC’s redemption calendar, trust account valuation methodology, sponsorship commitments, or merger deadline. It does not announce any amendment to the Business Combination Agreement, any proposed extension, or any change in sponsor conduct. The document simply reaffirms that closing remains contingent upon satisfying a $250 million minimum cash condition and restates TDAC’s existing executive team (Michael B. Hoffman as chief executive officer and chairman of the board of directors, Avanindra C. Das as chief financial officer) and board members (E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum, Christopher Jarratt) without indicating departures or equity adjustments. Why it matters: Although promotional and procedurally routine, the posting supplies unaudited operational and technological claims that investors should evaluate against execution risk ahead of the August 24, 2026 redemption deadline. According to the ProLogium-published communication, the company states it has delivered over 2.4 million battery cells worldwide and accumulated more than a decade of mass-production experience. ProLogium claims it holds over 1,100 global patents (granted and pending), launched a next-generation battery architecture featuring a 100% ceramic separator in 2013, introduced a superfluidized all-inorganic solid-state lithium ceramic battery in 2025, and received the Edison Awards Gold Award for that technology in 2026. The filing notes ProLogium possesses more than 13 years of manufacturing know-how, operates a Giga-scale demonstration facility in Taiwan, inaugurated a GWh-class gigafactory in Taoyuan in 2024, and shipped more than 800,000 cells from that location. For international scaling, ProLogium states it established an overseas R&D center in Paris-Saclay in May 2024, expects construction on a Dunkirk, France facility to begin in 2026, anticipates ramp-up beginning between Q4 2028 and Q1 2029, and plans formal mass production and deliveries in Q2 2029. The document explicitly warns that these projections involve material risks—including trade disputes, raw material sourcing, technology commercialization, market acceptance, and key personnel retention—and cautions that actual results may differ materially from corporate statements. Shareholders deciding whether to hold or redeem should treat these capacity and timeline assertions as forward-looking representations subject to regulatory, engineering, and capital execution uncertainties rather than confirmed delivery schedules.

What changed: A DEFA14A supplementary proxy solicitation filing submitted on June 23, 2026, which incorporates a Form 8-K and serves as the distribution channel for Exhibit 99.1, a press release dated June 22, 2026 announcing the final tabulation of shareholder votes and redemptions tied to a SPAC life extension vote and a proposed merger with ProLogium Holding Inc. In connection with the June 17, 2026 shareholder vote, 95% of votes cast favored extending the business combination deadline. Final redemption tabulations show public shareholders redeemed 2,598,697 Class A ordinary shares, while holders of 14,651,303 shares elected to remain. Following these pro-rata distributions, approximately $156.8mm now remains in the trust account. The filing's risk factor disclosures also explicitly reference a '$250 million Minimum Cash condition' required to close the transaction. Why it matters: Extending the deadline removes imminent liquidation pressure and pushes the redemption window beyond the original August 2026 horizon. The 85% retention rate leaves a $156.8mm trust balance, which management highlights as critical for meeting the newly cited $250 million minimum cash threshold. According to Chairman and CEO Michael Hoffman, shareholder enthusiasm stems from the May 27, 2026 merger announcement with ProLogium, which he claims is a 'global leader in next generation lithium ceramic battery technology.' Hoffman specifically asserts the company operates a gigascale plant in Taiwan and has a gigawatt plant in France under construction, backed by a French Government subsidy package potentially reaching up to 1.375 billion to serve electric vehicles, aerospace, robotics, defense, AI data centers, and maritime applications. The explicit anticipation of a forthcoming Form F-4 registration statement signals progression from preliminary discussions toward a definitive proxy/prospectus, where exact conversion ratios, PIPE equity pricing, and sponsor promissory note terms will be formally documented.

What changed: Form 8-K current report filed pursuant to Rule 425 containing a press release that announces the final tabulation of a June 17, 2026 shareholder vote regarding a SPAC life extension and share redemption elections. According to the June 22, 2026 press release, holders of 2,598,697 Class A shares redeemed their interests, leaving 14,651,303 shares continuing. Management characterized this outcome as 85% of shares not being redeemed, which left approximately $156.8mm in the trust account. The filing reports that 95% of the shares voted were in favor of the extension. The document confirms the pending business combination targets ProLogium Holding Inc. and references a forward-looking risk factor citing a '$250 million Minimum Cash condition' to closing. Why it matters: The extension approval and low redemption rate push the SPAC's deadline beyond the August 24, 2026 cutoff and preserve $156.8mm in trust capital, materially altering the financing footprint and timeline for the ProLogium transaction. CEO Michael Hoffman attributes the shareholder retention to 'excitement' around the deal, claiming ProLogium is a 'global leader in next-generation lithium ceramic battery technology' with a 'gigascale plant in Taiwan and a gigawatt plant in France under construction,' and points to an 'announced total potential subsidy package of up to 1.375 billion from the French Government.' He identifies target markets including electric vehicles, aerospace, robotics, defense, AI data centers, maritime, and energy storage systems that require 'high energy density, fast charging capabilities, enhanced safety, and manufacturability.' The filing's standard disclaimers simultaneously warn that actual results may differ due to risks surrounding the '$250 million Minimum Cash condition,' the ability to commercialize solid-state battery technology, forecast supply and demand, source raw materials, retain key personnel, and navigate U.S. and foreign tariffs.